# CLEARMIND MEDICINE INC (CMND)

> Institutional ownership reported to the SEC as of Q1 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CMND/

- Reporting holders: 4
- Reported value: $46.2K
- Shares held by institutions: 44,962 of 158,076 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [XTX Topco Ltd](https://holderbook.com/funds/1828301-xtx-topco-ltd/) | $22.6K | 21,694 | 0.0% | 1 |
| [HRT FINANCIAL LP](https://holderbook.com/funds/1475597-hrt-financial-lp/) | $16.0K | 15,910 | 0.0% | 1 |
| [AdvisorShares Investments LLC](https://holderbook.com/funds/1425930-advisorshares-investments-llc/) | $7.7K | 7,357 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $1 | 1 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2026 | 4 | $46.2K |
| Q4 2025 | 2 | $12.0K |
| Q3 2025 | 7 | $288.3K |
| Q2 2025 | 8 | $218.1K |
| Q1 2025 | 6 | $266.7K |
| Q4 2024 | 8 | $372.2K |
| Q3 2024 | 7 | $443.1K |
| Q2 2024 | 4 | $276.0K |
| Q1 2024 | 4 | $175.3K |
| Q4 2023 | 1 | $260.5K |
| Q3 2023 | 6 | $137.1K |
| Q2 2023 | 7 | $115.4K |